Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Basware BAS1V Aug 7, 2020 34.40 0.00   
 BBS-Bioactive Bone Substitutes BONEH Aug 7, 2020 4.26 +6.50   
 Bilot Plc BILOT Aug 7, 2020 6.95 0.00   
 Biohit B BIOBV Aug 7, 2020 2.70 -0.37   
 Bittium BITTI Aug 7, 2020 6.49 +0.93   
 CapMan CAPMAN Aug 7, 2020 2.00 +1.94   
 Cargotec CGCBV Aug 7, 2020 26.52 +1.14   
 Caverion CAV1V Aug 7, 2020 6.19 +0.32   
 Citycon CTY1S Aug 7, 2020 6.45 0.00   
 Componenta CTH1V Aug 7, 2020 0.07 -3.06   
 Consti Plc CONSTI Aug 7, 2020 8.58 -1.15   
 Detection Technology DETEC Aug 7, 2020 19.20 +1.05   
 Digia DIGIA Aug 7, 2020 5.90 +8.06   
 Digitalist Group DIGIGR Aug 7, 2020 0.03 0.00   
 Dovre Group DOV1V Aug 7, 2020 0.27 0.00   
 EAB Group EAB Aug 7, 2020 2.08 -0.95   
 Efecte PLC EFECTE Aug 7, 2020 4.62 -0.43   
 Elecster A ELEAV Aug 7, 2020 7.60 +1.33   
 Elisa ELISA Aug 7, 2020 50.36 +0.86   
 Endomines ENDOM Aug 7, 2020 0.70 -2.23   
 Endomines ENDO Aug 7, 2020 7.20 -1.91   
 Enedo Plc ENEDO Aug 7, 2020 1.60 -2.43   
 Enento Group Plc ENENTO Aug 7, 2020 34.40 -1.71   
 eQ EQV1V Aug 7, 2020 14.00 +4.87   
 Ericsson B ERIBR Aug 7, 2020 9.85 +1.36   
 Etteplan ETTE Aug 7, 2020 9.10 -0.44   
 Evli Pankki EVLI Aug 7, 2020 9.04 +0.44   
 Exel Composites EXL1V Aug 7, 2020 5.82 -0.34   
 F-Secure FSC1V Aug 7, 2020 2.94 -0.17   
 Faron Pharmaceuticals Oyj FARON Aug 7, 2020 4.70 +4.21   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK